CustoMED Closes $6M Seed Round to Automate 3D Printing of Patient-Specific Surgical Instruments

Why It Matters

By delivering same‑day, customized instruments, CustoMED dramatically reduces operative preparation time and expense, expanding personalized surgery beyond high‑volume procedures and reshaping orthopedic care delivery.

Key Takeaways

• Automates PSI creation, cutting weeks to same‑day production
• AI trains on massive CT datasets for faster segmentation
• Platform supports shoulder, knee, hip, oncology, beyond single surgery
• Seed round raised $6 million for printer deployment and partnerships
• Global surgeon network spans Europe, Asia, Australia, South America

Pulse Analysis

The convergence of 3D printing and artificial intelligence is redefining how surgeons prepare for complex operations. Traditional workflows require external labs to fabricate patient‑specific instruments, often taking weeks and incurring steep fees. CustoMED’s automated pipeline ingests imaging data, runs proprietary segmentation algorithms, and outputs printable files within hours, effectively turning any equipped operating suite into a rapid‑prototyping hub. This shift not only trims costs but also shortens the pre‑operative planning window, enabling clinicians to adapt tools on the day of surgery.

Beyond speed, CustoMED’s platform distinguishes itself through breadth. While many startups focus on a single procedure, the company’s software accommodates shoulder, knee, hip, and oncologic resections, and it has demonstrated feasibility in maxillofacial and plastic surgery. By training on a growing repository of CT scans, the AI improves accuracy with each case, delivering instruments that match patient anatomy more precisely than generic sets. Partnerships with major implant manufacturers further integrate personalized tools into existing surgical kits, creating a seamless supply chain that can scale across specialties.

The recent $6 million seed round provides the capital needed to embed 3D printers directly within hospitals, turning the concept of on‑demand PSI into a practical reality. As more clinics adopt this technology, the volume of customized cases is expected to surge, prompting a ripple effect across the orthopedic market. Faster turnaround, lower per‑case costs, and expanded procedural coverage position CustoMED to become a pivotal player in the next generation of value‑based surgical care. Its growth trajectory will likely attract additional venture interest and could accelerate regulatory pathways for patient‑specific devices.

Deal Summary

CustoMED, a platform that automates 3D printing of patient‑specific surgical instruments, announced it has closed a $6 million seed round. The funding will support scaling its automation technology, placing 3D printers in clinics and hospitals, and expanding its partnership with implant manufacturers.